Literature DB >> 8083352

Internalization of type 1 complement receptors and de novo multivesicular body formation during chemoattractant-induced endocytosis in human neutrophils.

M Berger1, E Wetzler, J T August, A M Tartakoff.   

Abstract

Upon activation of human neutrophils by chemoattractants, functionally important proteins are rapidly transported from intracellular granules and storage vesicles to the plasma membrane. This is accompanied by a marked increase in the rate of endocytosis and by ligand-independent internalization of type 1 complement receptors (CR1). To define the pathway of endocytosis, we used gold-conjugated BSA in a pulse-chase protocol. This tracer was initially internalized into small endocytic vesicles which rapidly traversed the cytoplasm and coalesced to form large, conspicuous multivesicular bodies. Within 5 min after addition of the chemoattractant, multivesicular bodies contained > 60% of the cell-associated BSA-gold. CR1 colocalized with the endocytic tracer in both the early endosomes and multivesicular bodies. In unstimulated cells, there was much less uptake of BSA-gold and multivesicular bodies were rarely seen. Using the acidotropic amine, DAMP, and anti-DNP antibodies, we found that the multivesicular bodies were acidified but the early endosomes did not concentrate DAMP. Neither the early endosomes nor the multivesicular bodies initially contained the lysosomal membrane antigens hLAMP 1 or 2, but hLAMP-positive structures subsequently joined the multivesicular bodies. The rapid activation of the endocytic pathway upon stimulation of neutrophils allowed us to visualize the de novo formation and maturation of multivesicular bodies. Our observations suggest that vesicles containing ion pumps and acid hydrolases fuse with multivesicular bodies, giving them characteristics of lysosomes, and that these are the probable sites of degradation of CR1. The observations do not support models which would require transport of CR1 from multivesicular bodies to defined, pre-existing lysosomes for degradation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083352      PMCID: PMC295175          DOI: 10.1172/JCI117426

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  Intracellular localization and de novo synthesis of FcRIII in human neutrophil granulocytes.

Authors:  C R Jost; T W Huizinga; R de Goede; J A Fransen; P A Tetteroo; M R Daha; L A Ginsel
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

2.  Intracellular degradation of the complement C3b/C4b receptor in the absence of ligand.

Authors:  J R Turner; A M Tartakoff; M Berger
Journal:  J Biol Chem       Date:  1988-04-05       Impact factor: 5.157

3.  On the origin of the FcRIII (CD16)-containing vesicle population in human neutrophil granulocytes.

Authors:  C R Jost; R de Goede; J A Fransen; M R Daha; L A Ginsel
Journal:  Eur J Cell Biol       Date:  1991-04       Impact factor: 4.492

4.  Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures.

Authors:  D T Fearon; L A Collins
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

5.  Kinase activity controls the sorting of the epidermal growth factor receptor within the multivesicular body.

Authors:  S Felder; K Miller; G Moehren; A Ullrich; J Schlessinger; C R Hopkins
Journal:  Cell       Date:  1990-05-18       Impact factor: 41.582

6.  Visualization of acidic organelles in intact cells by electron microscopy.

Authors:  R G Anderson; J R Falck; J L Goldstein; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

7.  Stimulus-dependent secretion of plasma proteins from human neutrophils.

Authors:  N Borregaard; L Kjeldsen; K Rygaard; L Bastholm; M H Nielsen; H Sengeløv; O W Bjerrum; A H Johnsen
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

8.  Intracellular sites for storage and recycling of C3b receptors in human neutrophils.

Authors:  M Berger; E M Wetzler; E Welter; J R Turner; A M Tartakoff
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

9.  Exocytotic exposure and recycling of membrane antigens of chromaffin granules: ultrastructural evaluation after immunolabeling.

Authors:  A Patzak; H Winkler
Journal:  J Cell Biol       Date:  1986-02       Impact factor: 10.539

10.  Temporal changes in pH within the phagocytic vacuole of the polymorphonuclear neutrophilic leukocyte.

Authors:  M S Jensen; D F Bainton
Journal:  J Cell Biol       Date:  1973-02       Impact factor: 10.539

View more
  5 in total

Review 1.  Molecular mechanisms regulating secretory organelles and endosomes in neutrophils and their implications for inflammation.

Authors:  Mahalakshmi Ramadass; Sergio D Catz
Journal:  Immunol Rev       Date:  2016-09       Impact factor: 12.988

2.  Nef proteins encoded by human and simian immunodeficiency viruses induce the accumulation of endosomes and lysosomes in human T cells.

Authors:  A Sanfridson; S Hester; C Doyle
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

3.  Fibrinogen is degraded and internalized during incubation with neutrophils, and fibrinogen products localize to electron lucent vesicles.

Authors:  Richard Kirsch; Mohamed A Jaffer; Vivienne E Woodburne; Trevor Sewell; Sharon L Kelly; Ralph E Kirsch; Enid G Shephard
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

4.  Counterregulation of clathrin-mediated endocytosis by the actin and microtubular cytoskeleton in human neutrophils.

Authors:  Silvia M Uriarte; Neelakshi R Jog; Gregory C Luerman; Samrath Bhimani; Richard A Ward; Kenneth R McLeish
Journal:  Am J Physiol Cell Physiol       Date:  2009-01-28       Impact factor: 4.249

5.  Munc13-4 interacts with syntaxin 7 and regulates late endosomal maturation, endosomal signaling, and TLR9-initiated cellular responses.

Authors:  Jing He; Jennifer L Johnson; Jlenia Monfregola; Mahalakshmi Ramadass; Kersi Pestonjamasp; Gennaro Napolitano; Jinzhong Zhang; Sergio D Catz
Journal:  Mol Biol Cell       Date:  2015-12-17       Impact factor: 4.138

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.